Question 1

Has Hassan Kanj received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $108,855 in general payments to Hassan Kanj across 1,066 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Hassan Kanj did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Hassan Kanj come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Novo Nordisk	333	$63,793
AstraZeneca(2 entities)	90	$28,334
Amarin Pharma, Inc.	4	$5,644
Johnson & Johnson	11	$1,893
Sanofi-aventis U.S. LLC	73	$1,088
Abbott	44	$812
Dexcom, Inc.	40	$694
Merck	54	$678
Amneal Pharmaceuticals LLC	46	$629
AbbVie(2 entities)	35	$443
Boehringer Ingelheim	30	$428
Medtronic(2 entities)	31	$423
Lilly USA, LLC	22	$374
Corcept Therapeutics	24	$374
Mannkind Corporation	22	$271
Novartis	8	$249
Radius Health, Inc.	18	$244
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	20	$214
IBSA Pharma Inc.	16	$211
Bayer	13	$185
Antares Pharma, Inc.	20	$170
Biohaven Pharmaceuticals, Inc.	6	$143
Esperion Therapeutics, Inc.	10	$141
Lifescan, Inc.	9	$119
Ultragenyx Pharmaceutical Inc.	7	$112
Amgen(2 entities)	8	$111
BD	8	$105
Kyowa Kirin, Inc.	6	$99
Xeris Pharmaceuticals, Inc.	6	$86
Eisai Inc.	6	$83
Embecta Corp.	5	$78
Pfizer	5	$70
Cequr Corporation	2	$69
Amryt Pharma Holdings Ltd	4	$63
Acerus Pharmaceuticals Corporation	4	$53
Kowa Pharmaceuticals America, Inc.	4	$53
Aytu Biopharma, Inc.	3	$43
Halozyme Inc	2	$35
Zealand Pharma US, Inc.	2	$30
Nalpropion Pharmaceuticals LLC	2	$30
Daiichi Sankyo Inc.	2	$29
OPKO Pharmaceuticals, LLC	2	$28
Currax Pharmaceuticals LLC	2	$26
Astellas Pharma US Inc	1	$22
Averitas Pharma Inc.	1	$18
Arbor Pharmaceuticals, Inc.	1	$15
Shire North American Group Inc	1	$15
Philips North America LLC	1	$14
Takeda Pharmaceuticals U.S.A., Inc.	2	$13

Hassan Kanj

Payments from drug & device makers

Who reported the general payments